Clinical Trial Update: To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the long-term safety and efficacy of pregabalin in patients with partial seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Seizure Disorder, Partial | Phase 3 | Status: COMPLETED